000

YUYU PHARMA

No trades
See on Supercharts
Market capitalization
‪74.71 B‬KRW
‪−7.18 B‬KRW
‪137.21 B‬KRW
‪9.70 M‬
Beta (1Y)
0.38

About YUYU PHARMA

CEO
Won-Sang Yu
Headquarters
Jecheon
Website
Employees (FY)
259
Founded
1941
ISIN
KR7000220004
FIGI
BBG000BDQTR7
Yuyu Pharma, Inc. engages in the manufacture and sale of pharmaceuticals. It operates through the Yuyu Pharmaceutical, Yuyu Healthcare, and Yuyu Medical Equipment. The company was founded on February 28, 1941 and is headquartered in Jecheon, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 000220 is 4590 KRW — it has decreased by 1.92% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange YUYU PHARMA stocks are traded under the ticker 000220.
YUYU PHARMA is going to release the next earnings report on Apr 15, 2024. Keep track of upcoming events with our Earnings Calendar.
000220 stock is 4.56% volatile and has beta coefficient of 0.38. Check out the list of the most volatile stocks — is YUYU PHARMA there?
Yes, you can track YUYU PHARMA financials in yearly and quarterly reports right on TradingView.
000220 stock has fallen by 3.67% compared to the previous week, the month change is a 6.13% fall, over the last year YUYU PHARMA has showed a 25.97% decrease.
000220 net income for the last quarter is ‪−1.09 B‬ KRW, while the quarter before that showed ‪−2.73 B‬ KRW of net income which accounts for 60.22% change. Track more YUYU PHARMA financial stats to get the full picture.
Today YUYU PHARMA has the market capitalization of ‪75.74 B‬, it has decreased by 4.46% over the last week.
Yes, 000220 dividends are paid annually. The last dividend per share was 105.00 KRW. As of today, Dividend Yield (TTM)% is 2.24%. Tracking YUYU PHARMA dividends might help you take more informed decisions.
Like other stocks, 000220 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade YUYU PHARMA stock right from TradingView charts — choose your broker and connect to your account.
000220 reached its all-time high on Apr 16, 2021 with the price of 18950 KRW, and its all-time low was 1180 KRW and was reached on Jun 22, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 259.00 employees. See our rating of the largest employees — is YUYU PHARMA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So YUYU PHARMA technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating YUYU PHARMA stock shows the sell signal. See more of YUYU PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. YUYU PHARMA EBITDA is ‪4.86 B‬ KRW, and current EBITDA margin is 3.54%. See more stats in YUYU PHARMA financial statements.